Tillis files 101 reform bill; Major Avanci hire; Patent loss causes Bausch stock tumble; UK publishes SEP feedback; New WDTX judge’s lack experience; plus much more
Everything we covered on IAM over the last seven days – and all you need to know from the global IP market to set yourself up for the start of another busy week
Access all areas
With the latest news, analysis and data from the global IP market, an IAM subscription enables you to make effective decisions and advise with confidence. To learn more about how to secure full, unlimited access to the platform, contact [email protected]
The Long Read
No commonly used patent valuation methods are much help at putting a number on an entire portfolio unless there is a specific transaction on the horizon. Cipher’s Nigel Swycher and Steve Harris suggest an original approach to fill this gap. Read more here
MONDAY 1 August
Merck has been attacked by the chair of the Senate Finance Committee, who accused the company of using its patents to sidestep billions of dollars in US taxes. Read more here
Avanci has announced the appointment of Marianne Frydenlund as vice president with a brief “to develop and lead new programs for the Internet of Things beyond the automotive industry”. Read more here
A deep dive on Docket Navigator shows that, Alan Albright aside, just two of the 12 judges on the new, random, Waco, WDTX, case assignment list have significant patent case experience. Read more here
TUESDAY 2 August
The number of invention patent grants in China topped 393,000 during the first half of 2022, up 16% on the same period last year. Read more here
In an exclusive interview, UK IP Office head Tim Moss reviews the five years he spent leading the agency and provides an update on its current study of SEP/FRAND policy issues. Read more here
Experts consulted by IAM generally support a recently announced USPTO revisit of patent examiner guidance relating to subject matter eligibility. Read more here
WEDNESDAY 3 August
The invalidation of US patent rights underpinning the anti-intestinal-infection drug Xifaxan has led to a huge drop in Bausch’s share price. Read more here
Senator Thom Tillis has filed 101 reform legislation that will effectively overturn US Supreme Court precedents set in the Alice, Mayo and Myriad decisions. Read more here
THURSDAY 4 August
Senior patent decision makers at four companies explain why both quality and quantity matter when you are building a strong portfolio of assets. Read more here
The US Court of Appeals for the Seventh Circuit has ruled that AbbVie’s patent thicketing strategy to extend exclusivity on best-selling drug Humira does not contravene antitrust law. Read more here
A US judge has rejected claims that compliance with the GDPR meant Continental was forced to heavily redact documents asked for in discovery by an NPE pursuing a case of patent infringement. Read more here
FRIDAY 5 August
IP-backed lending is becoming more mainstream as companies realise that utilising patents for collateral can save expense or even provide capital when VC or traditional lenders refuse. Read more here
The UK IP Office has published a summary of the responses it received to a call for views on SEP and FRAND licensing issues, but possible changes to the current regime are a long way off. Read more here
InterDigital has announced a 42% increase in total revenue year-over-year to $125 million in its Q2 earnings report, as well as a new multi-year licensing deal with Amazon. Read more here
SATURDAY 6 August
Former CAFC Chief Judge Paul Michel and ex-USPTO Director David Kappos urge Congress to embrace recently introduced legislation designed to repair patent eligibility law. Read more here
